- Endo Reports Fourth-Quarter And Full-Year 2019 Financial Results
- Endo Names Blaise Coleman President and Chief Executive Officer
- Endo Appoints Mark G. Barberio to Board of Directors
- Endo Begins Shipment of Authorized Generic Version of Carafate® (sucralfate) Oral Suspension in the United States
- Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results
- Endo Settles Opioid Investigation with State of Oklahoma for $8.75 million
Endo International PLC (EO7:BRN) closed at 5.91, -24.45% below its 52-week high of 7.83, set on Apr 30, 2019.
2.19Aug 15 20197.83Apr 30 2019
Markit short selling activity
|Market cap||787.11m USD|
|EPS (TTM)||-1.59 |
Data delayed at least 15 minutes, as of Feb 27 2020.